Jongmin Hwang

Introduction The optimal management strategy in patients with atrial fibrillation (AF) who have left atrial (LA) and left atrial appendage thrombi (LAAT) is still elusive. Vitamin K antagonist administration (with heparin bridging) and rigorous INR monitoring until resolution of the thrombi are generally accepted.

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.

Introduction Statins play major roles in treating patients with atherosclerotic cardiovascular disease by preventing the progression and stabilization of atherosclerosis.1-4 The current guidelines recommend to achieve optimal low-density lipoprotein cholesterol (LDL-C) with a maximally tolerated statin-based intensive lipid-lowering therapy (LLT) in these patients.5,6 The strong recommendations in the guidelines are supported by evidence from large randomized trials and meta-analyses that...